[Dangerous and useless drugs in Spain and in other Mediterranean countries]

[Dangerous and useless drugs in Spain and in other Mediterranean countries] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Dangerous and useless drugs in Spain and in other Mediterranean countries] Abstract Text:

[Dangerous and useless drugs in Spain and in other Mediterranean countries] Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

[Dangerous and useless drugs in Spain and in other Mediterranean countries] Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Tidsskrift for den Norske lægeforening : tidsskrif

VOLUME: 98

Page Numbers: 210-2

Journal Abbreviation: Tidsskr. Nor. Laegeforen.

ISSN: 0029-2001

DAY: 10

MONTH: Feb

YEAR: 1978

[Dangerous and useless drugs in Spain and in other Mediterranean countries] Information

Number of References:

LANGUAGE: nor

NlmUniqueID: 413423

[Dangerous and useless drugs in Spain and in other Mediterranean countries] Keywords Mesh Terms:

KEYWORDS: Travel

MESH TERMS: prevention & control

Chemical & Substance for Abstract: [Dangerous and useless drugs in Spain and in other Mediterranean countries] Information

Substance Name: Placebos

Registry Number: 0

Grant and Affiliation Information for [Dangerous and useless drugs in Spain and in other Mediterranean countries]

AFFILIATION:

Country: NORWAY

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Tidsskr Nor Laegeforen

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Dangerous and useless drugs in Spain and in other Mediterranean countries Related Publications

• Alterations in T-cell subset frequency in peripheral blood in obesity.
• Cell-cycle-dependent binding kinetics for the early endosomal tethering factor EEA1.
• Children, resilience and disasters: recent evidence that should influence a model of psychosocial care.
• Clinical experience with depot neuroleptics.
• Does smoking affect the outcome of patient education and self-management in asthmatics?
• Factors affecting growth of FEV1.
• Host-based identification is not supported by morphometrics in natural populations of Gyrodactylus salaris and G. thymalli (Platyhelminthes, Monogenea).
• Human PARM-1 is a novel mucin-like, androgen-regulated gene exhibiting proliferative effects in prostate cancer cells.
• No increase in response rate by adding a web response option to a postal population survey: a randomized trial.
• Phosphorylation of steroidogenic factor 1 is mediated by cyclin-dependent kinase 7.
• Respiratory symptoms, COPD severity, and health related quality of life in a general population sample.
• ["Phenacetin-kidney" or "analgetic-nephropathy"]
• [2 simple diagnostic procedures in stress incontinence in women]
• [Breakdown of organic nitrates in liver. Few arguments against oral administration of nitro compounds in angina pectoris]
• [Choice of analgesic in myocardial infarct]
• [Dangerous and useless drugs in Spain and in other Mediterranean countries]
• [Data technics in information systems. Promises and threats]
• [Extra-uterine pregnancy with intra-uterine prevention]
• [Follow up of urinary tract problems in adults with myelomeningocele]
• [Hallucinations in diphenhydramine poisoning]
• [In Process Citation]
• [Neuroradiological imaging of the 3rd, 4th and 6th cranial nerves]
• [Nonpuerperal chronic inversion of the uterus]
• [Periarthritis calcarea carpi]
• [Prolonged pregnancy--selection of pregnant women for induced labor]
• [Terror against the free world--politics and the Norwegian Medical Society]
• [The effect of patient education in asthma, a randomized controlled trial]
• [Time of crisis is time of possibilities--securing the recruitment with the help of the listed patients' system]
• [Usefulness of SPECT and MRI in the diagnosis of atypical parkinsonism]
• [Voiding problems and urinary tract complications in adolescents and adults with myelomeningocele]